Coronavirus Disease 2019 (COVID-19) Pipeline of Small and Mid-Cap Bio/Pharma Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Scope
This 28-page PowerPoint based report gives an important expert analysis on how the developement of vaccines and therapeutics for COVID-19 has been approached by Small and Mid Cap Bio/Pharma Companies. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.
Reasons to Buy
An overview of how Small and Mid Cap Bio/Pharma Companies have approached the developemnt of vaccines and therapeutics for the COVID-19 pandemic.
CanSino Biologics Inc
Novavax Inc
Swedish Orphan Biovitrum AB
Biohaven Pharmaceutical Holding Company Ltd
FibroGen Inc
Cytodyn Inc
Insmed Inc US
Mesoblast Ltd
Humanigen Inc
Vanda Pharmaceuticals Inc
Athersys Inc
Abivax SA
Dynavax Technologies Corp
Vir Biotechnology
Akers Biosciences Inc
InflaRx
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.